Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
64.226,63
-0,96%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
30/09/202111:00TipRanksWhat Does Blueprint Medicines’ Newly Added Risk Factor Reveal?NASDAQ:BPMCBlueprint Medicines Corporation
27/09/202122:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
03/09/202122:01PR Newswire (US)Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
02/09/202114:00PR Newswire (US)Blueprint Medicines to Present at Morgan Stanley 19th Annual Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
29/07/202122:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
29/07/202113:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
29/07/202113:00PR Newswire (US)Blueprint Medicines Reports Second Quarter 2021 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
28/07/202114:00PR Newswire (US)MD Anderson and Blueprint Medicines Announce Strategic Collaboration to Accelerate BLU-222 DevelopmentNASDAQ:BPMCBlueprint Medicines Corporation
22/07/202114:00PR Newswire (US)Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021NASDAQ:BPMCBlueprint Medicines Corporation
01/07/202122:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BPMCBlueprint Medicines Corporation
16/06/202122:43Dow Jones NewsBlueprint Medicines: FDA Approves Ayvakit to Treat Adults With Advanced Systemic MastocytosisNASDAQ:BPMCBlueprint Medicines Corporation
16/06/202121:50PR Newswire (US)FDA Approves Blueprint Medicines' AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic MastocytosisNASDAQ:BPMCBlueprint Medicines Corporation
07/06/202114:43TipRanksWhere Does Blueprint Medicines Stand Ahead of Anticipated FDA Decision on Avapritinib?NASDAQ:BPMCBlueprint Medicines Corporation
25/05/202114:00PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor ConferencesNASDAQ:BPMCBlueprint Medicines Corporation
21/05/202122:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BPMCBlueprint Medicines Corporation
19/05/202123:00PR Newswire (US)Blueprint Medicines Presents ARROW Trial Data for GAVRETO® (pralsetinib) Highlighting Durable Clinical Activity in Patients ...NASDAQ:BPMCBlueprint Medicines Corporation
17/05/202114:00PR Newswire (US)Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific OfficerNASDAQ:BPMCBlueprint Medicines Corporation
29/04/202113:00PR Newswire (US)Blueprint Medicines Reports First Quarter 2021 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
22/04/202114:00PR Newswire (US)Blueprint Medicines to Report First Quarter 2021 Financial Results on Thursday, April 29, 2021NASDAQ:BPMCBlueprint Medicines Corporation
21/04/202122:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BPMCBlueprint Medicines Corporation
21/04/202122:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BPMCBlueprint Medicines Corporation
11/04/202120:00PR Newswire (US)Blueprint Medicines Data Highlight Clinical Leadership in Systemic Mastocytosis at AACR Annual Meeting 2021NASDAQ:BPMCBlueprint Medicines Corporation
10/04/202114:30PR Newswire (US)Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2...NASDAQ:BPMCBlueprint Medicines Corporation
05/04/202114:00PR Newswire (US)Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday,...NASDAQ:BPMCBlueprint Medicines Corporation
17/03/202122:49Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BPMCBlueprint Medicines Corporation
10/03/202122:30PR Newswire (US)Blueprint Medicines to Showcase Scientific Leadership in Precision Oncology and Hematology at AACR Annual Meeting 2021NASDAQ:BPMCBlueprint Medicines Corporation
03/03/202114:00PR Newswire (US)Blueprint Medicines Announces EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapriti...NASDAQ:BPMCBlueprint Medicines Corporation
17/02/202122:52Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BPMCBlueprint Medicines Corporation
17/02/202113:00PR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
10/02/202116:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

LSE
USPR
Ish Mscit Uspr
LSE
WWH
Worldwide Healthcare
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network